top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy : Future Perspectives
Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy : Future Perspectives
Autore Vermehren Charlotte
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (224 p.)
Soggetto topico Manufacturing industries
Medicine and Nursing
Soggetto non controllato 2019 Beers criteria
5'nuclease assay
80 and over
abacavir
acute kidney injury
adverse drug reaction
adverse drug reactions
aged
allopurinol
antidepressants
antiepileptic drugs
antipsychotics
appropriateness
bleeding
children
chronic
clinical pharmacist
clozapine
CNV
copy number variation
cost-effectiveness
CYP1A2
CYP2D6
CYP2D7P
CYP2D8P
cytochrome P450
cytochromes
deprescribing
deprescriptions
determinants
digital decision-support
digital health
DOACs
drug hypersensitivity
drug information service
drug interaction checkers
drug metabolization
drug-drug interactions
drug-gene interactions
early biomarker
electronic medical record
electronic prescribing
emergency department
Ethiopia
exosomes
extracellular vesicles
flucloxacillin
general practice
genotyping
health outcomes
health services research
high resolution melting
HLA
hospital pharmacy service
HRM
loxapine
medication adherence
medication optimization
medication reconciliation
medication review
medication-based risk score
microvesicles
multimorbidity
nursing homes
olanzapine
older adults
older patients
outpatient
personalized medicine
persons with diabetes
pharmacogene expression
pharmacogenetics
pharmacogenomics
phenprocoumon
plasma neutrophil gelatinase-associated lipocalin
polypharmacy
population-based
potentially inappropriate medication use
prevalence
process evaluation
quality of life
shared medication record
SLCO1B1
soluble urokinase plasminogen activator receptor
thromboembolism
utility
youth
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Clinical Utility of Applying PGx and Deprescribing-Based Decision Support in Polypharmacy
Record Nr. UNINA-9910595072903321
Vermehren Charlotte  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Pharmacogenetics to Avoid Adverse Drug Reactions
Pharmacogenetics to Avoid Adverse Drug Reactions
Autore López-Fernández Luis A
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (220 p.)
Soggetto topico Medicine
Soggetto non controllato (es)citalopram
5-fluorouracil
acute coronary syndrome
adverse drug reactions
adverse events
allele
anti-epileptic drugs (AEDS)
antiepileptics
antipsychotic agents
atorvastatin
capecitabine
cardiology
cardiovascular disease
clinical implementation
clopidogrel
colorectal cancer
cutaneous adverse drug reaction
cutaneous adverse drug reactions (CADRs)
CYP2C9*3
CYP450 enzymes
cytochrome P-450 enzyme system
direct oral anticoagulants
drug-drug-gene-interaction
drug-drug-interaction
drug-gene-interaction
epistasis
fluoropyrimidine
genetic polymorphism
genetic risk factors
genotype
guidelines
HLA
HLA B
India
n/a
personalised medicine
pharmacogenetics
pharmacogenomics
phenytoin (PHT)
platelet reactivity
polymorphism
precision medicine
psychotic disorders
random forest
SCAR
single-nucleotide variants
SLCO1B1
South India
statin
the PharmLines initiative
thymidylate synthase
thymidylate synthase enhancer region
toxicity
upstream stimulatory factor 1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557610103321
López-Fernández Luis A  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui